Citations

Institution: Mayo Clinic Clear

Showing 10 of 107969 citations.

Differences in the phospholipid, cholesterol, and fatty acyl composition of 3T3 and SV3T3 plasma membranes
Perkins, Roger, Scott, Robert E.

Lipids | November 22, 2006 | Volume: 13 | Issue: 10 | Pages: 653-657

10.1007/bf02533741 | PMID 214660 Get It

AbstractAn analysis of the phospholipid, cholesterol, and phospholipid fatty acyl composition of isolated plasma membranes of 3T3 and SV3T3 mouse embryo cells has been performed. The results show that the plasma membrane of SV3T3 cells contain relatively less phosphatidylethanolamine and sphingomyelin and more cholesterol than 3T3 plasma membranes. The fatty acyl composition of individual phospholipid classes as determined by gas liquid chromatography also showed differences between 3T3 and SV3T3 plasma membranes. The plasma membranes of SV40 transformed 3T3 cells contain: (a) a higher percentage of 18∶1 and less 20∶3 and 20∶4 in phosphatidylethanolamine; (b) a higher percentage of 18∶1 in phosphatidylserine; and (c) a higher percentage of 18∶2 and 20∶4 in phosphatidylinositol.
Plasma membrane phospholipid, cholesterol and fatty acyl composition of differentiated and undifferentiated L6 myoblasts
Perkins, Roger, Scott, Robert E.

Lipids | November 22, 2006 | Volume: 13 | Issue: 5 | Pages: 334-337

10.1007/bf02533724 | PMID 672469 Get It

AbstractThe lipid composition of plasma membranes isolated from differentialted and undifferentiated L6 myoblasts has been compared. In general, the plasma membranes of differentiated L6 myoblasts have a higher cholesterol to phospholipid molar ratio than plasma membranes of undifferentiated cells. Differentiated L6 myoblasts have increased relative amounts of phosphatidylethanolamine and phosphatidylcholine in their plasma membrane and a decreased relative amount of sphingomyelin when compared with the plasma membranes of undifferentiated myoblasts. In addition, preliminary results show that differentiated L6 myoblasts plasma membrane phospholipid shows differences in the fatty acyl composition, specifically there appears to be relatively more 17∶0 and 24∶1 and less 16∶1 and 18∶1 than in plasma membrane phospholipids of undifferentiated L6 myoblasts. These observations indicate that significant changes in plasma membrane lipid composition occur during myoblast differentiation. The role that changes in lipid composition play in control of cellular differentiation, however, remains to be elucidated.
A comparison of simplified methods for lipoprotein quantification using the analytic ultracentrifuge as a standard
Lindgren, F. T., Jutagir, Rajendra, Layshot, L., Bradley, Douglas D., Lindgren, Frank T., Silvers, Abraham

Lipids | November 22, 2006 | Volume: 12 | Issue: 3 | Pages: 278-282

10.1007/bf02533347 | PMID 191719 Get It

AbstractTwo simplified methods for quantitative lipoprotein analysis have been calibrated and compared with each other using analytic ultracentrifugation as a standard reference procedure. The first method was the Friedewald procedure and the second was an automated agarose gel electrophoresis system. Both procedures offer comparable quantitative lipoprotein analysis with potential for large scale screening purposes at low cost ($4.00–$5.00 per analysis). There were advantages and limitations to both procedures. The Friedwald procedure can be used on frozen sera but requires 3 ml sera. In contrast, the electrophoresis system must be used with fresh serum but requires only 50 μl serum and the electrophoretic slides may be quantitatively analyzed several years retrospectively.
Cholestanol and plant sterols in pigeon skin
Subbiah, M.T.R.

Lipids | November 22, 2006 | Volume: 8 | Issue: 3 | Pages: 158-160

10.1007/bf02531815 | PMID 4692885 Get It

AbstractCholestanol (4.6%) and plant sterols (0.2%) have been demonstrated, for the first time, in avian skin by argentation and gas liquid chromatography. In contrast to results of previous studies with rat and human skin, cholestanol represented a significant amount in the pigeon. The proportion of campesterol was always higher than that of β‐sitosterol.
A comparison of the absorption of oleic acid in vitro as measured isotopically and by titration
Hoffman, NE

Lipids | November 22, 2006 | Volume: 7 | Issue: 8 | Pages: 559-561

10.1007/bf02533025 Get It

AbstractUptake of oleic acid by the everted sac of rat intestine has been shown to be net absorption and not merely exchange. Sodium fluoride, 10 mM, has been shown to inhibit absorption of oleic acid.
Gene Expression Profiling on Lung Cancer Outcome Prediction: Present Clinical Value and Future Premise
Sun, Zhifu , Yang, Ping , Sun, Zhifu

Cancer Epidemiology, Biomarkers & Prevention | November 21, 2006 | Volume: 15 | Issue: 11 | Pages: 2063-2068

10.1158/1055-9965.epi-06-0505 | PMID 17119029 Get It

Abstract DNA microarray has been widely used in cancer research to better predict clinical outcomes and potentially improve patient management. The new approach provides accurate tumor classification and outcome predictions, such as tumor stage, metastatic status, and patient survival, and offers some hope for individualized medicine. However, growing evidence suggests that gene-based prediction is not stable and little is known about the prediction power of gene expression profiles compared with well-known clinical and pathologic predictors. This review summarized up-to-date publications in microarray-based lung cancer clinical outcome prediction and conducted secondary analyses for those with sufficient sample sizes and associated clinical information. Among the most commonly used analytic approaches, unsupervised clustering mainly recaptures tumor histology and provides variable degrees of prediction for tumor stage, lymph node status, or survival. Overall, most studies lack an independent validation. Supervised learning and testing generally offer a better prediction. Noted is that when conventional predictors of age, gender, stage, cell type, and tumor grade are considered collectively, the predictive advantage of the gene expression profiles diminishes. We conclude that outcome prediction from gene expression signatures selected by current analytic approaches can be mostly explained by well-known conventional predictors, particularly histologic subtype and grade of differentiation. A strategy for establishing independent or more accurate signatures is commented. (Cancer Epidemiol Biomarkers Prev 2006;15(11):2063–8)
Methylenetetrahydrofolate Reductase Haplotype Tag Single-Nucleotide Polymorphisms and Risk of Breast Cancer
Martin, Yvette N. , Vierkant, Robert A. , Fredericksen, Zachary S., Wu, Yanhong , Schaid, Daniel J. , Sellers, Thomas A. , Weinshilboum, Richard M. , Olson, Janet E. , Ingle, James N. , Pankratz, V. Shane , Weinshilboum, Richard M. , Vierkant, Robert A

Cancer Epidemiology, Biomarkers & Prevention | November 21, 2006 | Volume: 15 | Issue: 11 | Pages: 2322-2324

10.1158/1055-9965.epi-06-0318 | PMID 17119067 Get It

Getting the Picture
Farrell, Ann

Medical Reference Services Quarterly | November 21, 2006 | Volume: 25 | Issue: 4 | Pages: 47-54

10.1300/j115v25n04_05 | PMID 17135151 Get It

5α‐cholestan‐3β‐ol: High concentration in testis of white carneau pigeon
Subbiah, M.T.R., Kottke, Bruce A., Carlo, Ivette A.

Lipids | November 21, 2006 | Volume: 6 | Issue: 7 | Pages: 517-519

10.1007/bf02531238 | PMID 5120789 Get It

Abstract5α‐Cholestan‐3β‐ol (cholestanol) was isolated from the testes of White Carneau pigeons in the highest concentration thus far reported in any animal tissue. It contributed 26% to 28% of the total sterols (384±29.4 μg cholestanol per gram of wet tissue) in testis, and about 27% of it was esterified. The identity of this stanol was confirmed by AgNO3 thin layer chromatography, gas liquid chromatography and mass spectrometry. Ovaries, liver, plasma and other tissues of this pigeon contained this stanol only to the extent of 2% to 10% of total sterols.
Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model
Abrey, Lauren E. , Ben‐Porat, Leah, Panageas, Katherine S. , Curran, Walter J. , Schultz, Christopher J. , Leibel, Steven A., Nelson, Diana F., Mehta, Minesh P. , DeAngelis, Lisa M. , Price, Leah , Yahalom, Joachim , Berkey, Brian A. , Mehta, Minesh P , Price, Leah

Journal of Clinical Oncology | November 21, 2006 | Volume: 24 | Issue: 36 | Pages: 5711-5715

10.1200/jco.2006.08.2941 | PMID 17116938 Get It

Purpose The purpose of this study was to analyze prognostic factors for patients with newly diagnosed primary CNS lymphoma (PCNSL) in order to establish a predictive model that could be applied to the care of patients and the design of prospective clinical trials. Patients and Methods Three hundred thirty-eight consecutive patients with newly diagnosed PCNSL seen at Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY) between 1983 and 2003 were analyzed. Standard univariate and multivariate analyses were performed. In addition, a formal cut point analysis was used to determine the most statistically significant cut point for age. Recursive partitioning analysis (RPA) was used to create independent prognostic classes. An external validation set obtained from three prospective Radiation Therapy Oncology Group (RTOG) PCNSL clinical trials was used to test the RPA classification. Results Age and performance status were the only variables identified on standard multivariate analysis. Cut point analysis of age determined that patients age ≤ 50 years had significantly improved outcome compared with older patients. RPA of 282 patients identified three distinct prognostic classes: class 1 (patients < 50 years), class 2 (patients ≥50; Karnofsky performance score [KPS] ≥ 70) and class 3 (patients ≥ 50; KPS < 70). These three classes significantly distinguished outcome with regard to both overall and failure-free survival. Analysis of the RTOG data set confirmed the validity of this classification. Conclusion The MSKCC prognostic score is a simple, statistically powerful model with universal applicability to patients with newly diagnosed PCNSL. We recommend that it be adopted for the management of newly diagnosed patients and incorporated into the design of prospective clinical trials.